ACAD
36.99
+0.89
+2.47%
AEMD
0.97
-0.02
-2.02%
APRI
1.79
+0.01
+0.56%
ARNA
26.85
+1.29
+5.05%
ATEC
3.77
+0.06
+1.62%
CNAT
5.1
-0.22
-4.14%
CRXM
0.155
-0.005
-3.125%
CYTX
0.47
+0.012
+2.5322%
DXCM
44.99
+0.02
+0.04%
GNMK
8.11
-0.39
-4.59%
HALO
17.74
-0.12
-0.67%
ILMN
206.48
+0.25
+0.12%
INNV
0.087
-0.003
-2.8090%
INO
6.24
+0.03
+0.48%
ISCO
1.67
+0.04
+2.45%
ISIS
57.56
0.00
0.00%
LGND
142.15
+0.41
+0.29%
LPTN
2.93
-2.93
-100.00%
MBVX
0.73
+0.02
+2.8306%
MEIP
2.33
+0.01
+0.43%
MNOV
6.62
-0.03
-0.45%
MRTX
14.25
+0.55
+4.01%
MSTX
0.13
-0.01
0.00%
NBIX
60.87
-0.27
-0.44%
NUVA
53.71
+1.53
+2.93%
ONCS
1.21
+0.01
+0.83%
ONVO
1.52
+0.04
+2.70%
OREX
1.89
+0.06
+3.28%
OTIC
3.475
-0.125
-3.472%
QDEL
41.36
0.00
0.00%
RCPT
231.96
0.00
0.00%
RGLS
1.32
+0.04
+3.13%
RMD
78.42
+0.69
+0.89%
SCIE
0
0.00
-33.3333%
SPHS
2.28
-0.01
-0.44%
SRNE
2.85
-0.12
-4.20%
TROV
0.79
-0.01
-0.99%
VICL
2.53
-0.33
-11.54%
VOLC
18
0.00
0.00%
ZGNX
38.1
-0.45
-1.17%
ACAD
36.99
+0.89
+2.47%
AEMD
0.97
-0.02
-2.02%
APRI
1.79
+0.01
+0.56%
ARNA
26.85
+1.29
+5.05%
ATEC
3.77
+0.06
+1.62%
CNAT
5.1
-0.22
-4.14%
CRXM
0.155
-0.005
-3.125%
CYTX
0.47
+0.012
+2.5322%
DXCM
44.99
+0.02
+0.04%
GNMK
8.11
-0.39
-4.59%
HALO
17.74
-0.12
-0.67%
ILMN
206.48
+0.25
+0.12%
INNV
0.087
-0.003
-2.8090%
INO
6.24
+0.03
+0.48%
ISCO
1.67
+0.04
+2.45%
ISIS
57.56
0.00
0.00%
LGND
142.15
+0.41
+0.29%
LPTN
2.93
-2.93
-100.00%
MBVX
0.73
+0.02
+2.8306%
MEIP
2.33
+0.01
+0.43%
MNOV
6.62
-0.03
-0.45%
MRTX
14.25
+0.55
+4.01%
MSTX
0.13
-0.01
0.00%
NBIX
60.87
-0.27
-0.44%
NUVA
53.71
+1.53
+2.93%
ONCS
1.21
+0.01
+0.83%
ONVO
1.52
+0.04
+2.70%
OREX
1.89
+0.06
+3.28%
OTIC
3.475
-0.125
-3.472%
QDEL
41.36
0.00
0.00%
RCPT
231.96
0.00
0.00%
RGLS
1.32
+0.04
+3.13%
RMD
78.42
+0.69
+0.89%
SCIE
0
0.00
-33.3333%
SPHS
2.28
-0.01
-0.44%
SRNE
2.85
-0.12
-4.20%
TROV
0.79
-0.01
-0.99%
VICL
2.53
-0.33
-11.54%
VOLC
18
0.00
0.00%
ZGNX
38.1
-0.45
-1.17%
Home » Archive by Category

Xconomy

Patient Network Group Says Majority of Members Want To Keep Obamacare

June 14, 2017 – 12:05 pm

A U.S. patient networking group called PatientsLikeMe has dipped its toe in the waters of public opinion, asking its members what they think of the healthcare policy fight. There are many caveats,…

[[Click headline to continue reading.]]

Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall

June 12, 2017 – 4:25 am

It’s been a tough run for Regulus Therapeutics, and things haven’t gotten any better this morning. Regulus is scrapping two programs, and AstraZeneca has kicked back a third drug to boot, sending…

[[Click headline to continue reading.]]

Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal

June 12, 2017 – 3:55 am

Dragonfly Therapeutics, a stealthy startup formed by well-known cancer researchers on both coasts and backed by a high-powered group of family offices, has inked its first partnership. Celgene, of…

[[Click headline to continue reading.]]

Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More

June 9, 2017 – 2:30 am

The New York Times Magazine wrote a few weeks ago about the extraordinary metabolic changes in a python after it gulps down a 50,000 calorie meal. The biomedical world was like a postprandial python…

[[Click headline to continue reading.]]

ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity

June 6, 2017 – 9:10 am

[Note: Ben Fidler coauthored this report.] The American Society of Clinical Oncology conference is wrapping up, and the closely watched medical meeting-slash-hype machine produced its usual array of…

[[Click headline to continue reading.]]

Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests?

June 3, 2017 – 3:25 am

When the FDA last week approved Merck’s cancer drug pembrolizuamb (Keytruda) for tumors with a specific genetic signature, regardless of what body part they originated in, it was a watershed moment…

[[Click headline to continue reading.]]

Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More

June 2, 2017 – 2:00 am

Over the next four days, the Second City will be the center of the biomedical world. The American Society of Clinical Oncology’s annual meeting in Chicago brings together thousands of researchers…

[[Click headline to continue reading.]]

With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding

May 31, 2017 – 7:19 am

San Antonio — Most diabetes treatments work by giving the body the insulin it needs to break down sugar. But that approach deals with the symptoms of diabetes. In recent years, scientists and…

[[Click headline to continue reading.]]

As Big Cancer Trials Ramp Up, Grail Goes Global, Merges With Cirina

May 31, 2017 – 4:45 am

Grail, the Illumina (NASDAQ: ILMN) spinout aiming to develop a blood test that can detect cancer at its earliest stages, has gone global. The Menlo Park, CA, startup, is merging with China’s Cirina,…

[[Click headline to continue reading.]]

In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions

May 31, 2017 – 2:35 am

Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the…

[[Click headline to continue reading.]]